LC

Lichen Capital

Description

Lichen Capital is a Private Equity Firm.

Investor Profile

Lichen Capital has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Angel, Series B rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Angel (67%)
  • Series B (33%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Medical
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lichen Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Yonghua Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
3H Health Investment
Asia, Hong Kong Island, Hong Kong, Cyberport
Co-Investments: 1
Morningside Group
North America, Massachusetts, United States, Newton Center
Co-Investments: 1
Legend Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
BioTrack Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
V
North America, California, United States, San Mateo
Co-Investments: 1
Gaorong Capital
Asia, Beijing, China, Wangjing
Co-Investments: 1
Oriza Holdings
Asia, Jiangsu, China, Suzhou
Co-Investments: 1
Kaitai Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1

What are some of recent deals done by Lichen Capital?

Spurious

Shanghai, Shanghai, China

Spurious is the developer of the small molecule anti-tumordrug developers.

Health Care
AngelJun 4, 2025
Amount Raised: $27,834,994
Angitia Biopharmaceuticals

Guangzhou, Guangdong, China

Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics.

BiopharmaBiotechnologyHealth CareMedical
Series BOct 19, 2023
Amount Raised: $46,000,000
Bivision

Shanghai, Shanghai, China

Bivision is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT).

BiopharmaBiotechnologyHealth Diagnostics
AngelAug 10, 2022
Amount Raised: $14,872,542